Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 3063 to 3112 of 6456 in total 
Value Type: Ranked
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1532\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp,atp carrier protein, liver isoform t2 (adp/atp translocase 3) (adenine nucleotide translocator 3) (ant 3). [source:swissprot;acc:p12236]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.159\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.424\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.735\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
rna-binding protein 10 (rna binding motif protein 10) (dxs8237e). [source:swissprot;acc:p98175]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.419\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
232.376\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01732\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1533\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp,atp carrier protein, heart/skeletal muscle isoform t1 (adp/atp translocase 1) (adenine nucleotide translocator 1) (ant 1). [source:swissprot;acc:p12235]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.159\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.424\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.735\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome c. [source:swissprot;acc:p00001]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
228.419\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
232.376\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01732\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1534\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
heparan sulfate 6-o-sulfotransferase 2. [source:refseq;acc:nm\_147174]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial precursor (ec 2.7.1.115) (branched-chain alpha-ketoacid dehydrogenase kinase) (bckdhkin) (bckd-kinase). [source:swissprot;acc:o14874]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.259\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.524\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
3.735\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1535\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp,atp carrier protein, fibroblast isoform (adp/atp translocase 2) (adenine nucleotide translocator 2) (ant 2). [source:swissprot;acc:p05141]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
225.159\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.424\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
heparan sulfate 6-o-sulfotransferase; heparan-sulfate 6-sulfotransferase. [source:refseq;acc:nm\_004807]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.419\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
232.376\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01732\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1536\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
actin, cytoplasmic 2 (gamma-actin). [source:swissprot;acc:p02571]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.762\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.031\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.731\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
fatty acid hydroxylase domain containing 1. [source:refseq;acc:nm\_024306]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.419\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
232.376\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01732\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1537\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cysteine-rich motor neuron 1; cysteine-rich repeat-containing protein s52 precursor. [source:refseq;acc:nm\_016441]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.025\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.304\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.721\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ww domain binding protein 11; npw38-binding protein npwbp; sh3 domain-binding protein snp70. [source:refseq;acc:nm\_016312]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
228.419\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
232.376\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01732\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1538\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
elac homolog 2; putative prostate cancer susceptibility protein; elac (e. coli) homolog 2. [source:refseq;acc:nm\_018127]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
myb-related protein b (b-myb). [source:swissprot;acc:p10244]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.541\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.823\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.718\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1539\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
myb-related protein a (a-myb). [source:swissprot;acc:p10243]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
222.512\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.802\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.71\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
rna-binding protein 5 (rna binding motif protein 5) (putative tumor suppressor luca15) (g15 protein). [source:swissprot;acc:p52756]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.419\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
232.376\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01732\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1540\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
argininosuccinate synthase (ec 6.3.4.5) (citrulline--aspartate ligase). [source:swissprot;acc:p00966]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.769\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.474\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.705\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
autophagy protein 5-like (apg5-like) (apoptosis-specific protein). [source:swissprot;acc:q9h1y0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
240.077\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
236.015\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01721\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1541\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
importin-alpha re-exporter (chromosome segregation 1-like protein) (cellular apoptosis susceptibility protein). [source:swissprot;acc:p55060]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
192.336\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
188.637\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.699\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
myb proto-oncogene protein (c-myb). [source:swissprot;acc:p10242]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.672\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.92\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01714\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1542\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
orphan nuclear receptor nr2e1 (nuclear receptor tlx) (tailless homolog) (tll) (htll). [source:swissprot;acc:q9y466]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.762\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.081\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.681\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
trimethyllysine dioxygenase, mitochondrial precursor (ec 1.14.11.8) (epsilon-trimethyllysine 2-oxoglutarate dioxygenase) (tml-alpha- ketoglutarate dioxygenase) (tml hydroxylase) (tml dioxygenase) (tmld). [source:swissprot;acc:q9nvh6]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
213.546\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
209.965\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01706\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1543\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
gtp-binding protein era homolog (hera) (fragment). [source:swissprot;acc:o75616]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
orphan nuclear receptor tr2. [source:swissprot;acc:p13056]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.083\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.677\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1544\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
orphan nuclear receptor nr2e1 (nuclear receptor tlx) (tailless homolog) (tll) (htll). [source:swissprot;acc:q9y466]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.762\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.081\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01704\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
thymidylate synthase (ec 2.1.1.45) (ts) (tsase). [source:swissprot;acc:p04818]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
225.119\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
228.769\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
3.65\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1545\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dihydrofolate reductase (ec 1.5.1.3). [source:swissprot;acc:p00374]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
orphan nuclear receptor tr2. [source:swissprot;acc:p13056]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.083\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01702\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1546\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
argininosuccinate synthase (ec 6.3.4.5) (citrulline--aspartate ligase). [source:swissprot;acc:p00966]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
217.769\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.474\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01701\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
stromal cell-derived factor 2 precursor (sdf-2). [source:swissprot;acc:q99470]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.119\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
228.769\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.65\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1547\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
myb-related protein b (b-myb). [source:swissprot;acc:p10244]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.541\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.823\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01699\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
stromal cell-derived factor 2-like protein 1 precursor (sdf2 like protein 1) (pwp1-interacting protein 8). [source:swissprot;acc:q9hcn8]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.119\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
228.769\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.65\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1548\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 3 subunit 11 (eif-3 p25) (eif3k) (muscle specific gene m9 protein) (ptd001) (hspc029) (arg134). [source:swissprot;acc:q9ubq5]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
221.128\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.767\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.639\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
myb-related protein a (a-myb). [source:swissprot;acc:p10243]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.512\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.802\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01696\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1549\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dynactin complex 50 kda subunit (50 kda dynein-associated polypeptide) (dynamitin) (dctn-50) (dynactin 2). [source:swissprot;acc:q13561]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
225.159\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.424\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01687\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
erythroid differentiation and denucleation factor 1. [source:swissprot;acc:o60584]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.128\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.767\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.639\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1550\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp,atp carrier protein, liver isoform t2 (adp/atp translocase 3) (adenine nucleotide translocator 3) (ant 3). [source:swissprot;acc:p12236]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.159\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.424\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01687\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
bardet-biedl syndrome 7 protein isoform a; bbs2-like 1. [source:refseq;acc:nm\_176824]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.128\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.767\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.639\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1551\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp,atp carrier protein, heart/skeletal muscle isoform t1 (adp/atp translocase 1) (adenine nucleotide translocator 1) (ant 1). [source:swissprot;acc:p12235]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.159\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.424\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01687\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ba508n22.1 (hspc025) (fragment). [source:sptrembl;acc:q9hcw5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.128\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.767\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.639\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1552\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp,atp carrier protein, fibroblast isoform (adp/atp translocase 2) (adenine nucleotide translocator 2) (ant 2). [source:swissprot;acc:p05141]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.159\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.424\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01687\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
lipopolysaccharide-responsive and beige-like anchor protein (cdc4-like protein) (beige-like protein). [source:swissprot;acc:p50851]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.128\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.767\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.639\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1553\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenosylhomocysteinase (ec 3.3.1.1) (s-adenosyl-l-homocysteine hydrolase) (adohcyase). [source:swissprot;acc:p23526]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.389\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.833\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01679\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein c20orf45 (cgi-107). [source:swissprot;acc:q9y3b1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.128\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.767\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.639\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1554\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
c-terminal binding protein 1 (ctbp1). [source:swissprot;acc:q13363]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
196.215\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
193.018\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01656\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 3 subunit 6 interacting protein (hspc021/hspc025). [source:swissprot;acc:q9y262]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.128\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.767\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.639\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1555\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
pas domain containing serine/threonine kinase; pas-serine/threonine kinase. [source:refseq;acc:nm\_015148]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
196.192\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
192.996\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01656\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
putative rna-binding protein 7 (rna binding motif protein 7). [source:swissprot;acc:q9y580]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.128\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.767\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.639\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1556\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
b-cell lymphoma 6 protein (bcl-6) (zinc finger protein 51) (laz-3 protein) (bcl-5). [source:swissprot;acc:p41182]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
196.192\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
192.996\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01656\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
valyl-trna synthetase 2 (ec 6.1.1.9) (valine--trna ligase 2) (valrs 2) (g7a). [source:swissprot;acc:p26640]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.589\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
227.219\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.63\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/